» Articles » PMID: 28757285

Proposal of a New Adverse Event Classification by the Society of Interventional Radiology Standards of Practice Committee

Abstract

Purpose: To develop a new adverse event (AE) classification for the interventional radiology (IR) procedures and evaluate its clinical, research, and educational value compared with the existing Society of Interventional Radiology (SIR) classification via an SIR member survey.

Materials And Methods: A new AE classification was developed by members of the Standards of Practice Committee of the SIR. Subsequently, a survey was created by a group of 18 members from the SIR Standards of Practice Committee and Service Lines. Twelve clinical AE case scenarios were generated that encompassed a broad spectrum of IR procedures and potential AEs. Survey questions were designed to evaluate the following domains: educational and research values, accountability for intraprocedural challenges, consistency of AE reporting, unambiguity, and potential for incorporation into existing quality-assurance framework. For each AE scenario, the survey participants were instructed to answer questions about the proposed and existing SIR classifications. SIR members were invited via online survey links, and 68 members participated among 140 surveyed. Answers on new and existing classifications were evaluated and compared statistically. Overall comparison between the two surveys was performed by generalized linear modeling.

Results: The proposed AE classification received superior evaluations in terms of consistency of reporting (P < .05) and potential for incorporation into existing quality-assurance framework (P < .05). Respondents gave a higher overall rating to the educational and research value of the new compared with the existing classification (P < .05).

Conclusions: This study proposed an AE classification system that outperformed the existing SIR classification in the studied domains.

Citing Articles

Model Predicting Survival in Intermediate-Stage HCC Patients Reclassified for TACE Based on the 2022 BCLC Criteria.

Kim J, Kim J, Ko E, Kim J, Im B, Kim G Cancers (Basel). 2025; 17(5).

PMID: 40075741 PMC: 11898427. DOI: 10.3390/cancers17050894.


CT-guided high-dose-rate brachytherapy ablation of HCC patients with portal vein tumor thrombosis.

Auer T, Ranner-Hafferl M, Anhamm M, Boning G, Fehrenbach U, Mohr R Eur Radiol Exp. 2025; 9(1):16.

PMID: 39951200 PMC: 11828765. DOI: 10.1186/s41747-025-00564-3.


Feasibility and Safety of Cone-Beam Computed Tomography Advanced Navigation to Optimize Intra-arterial Chemotherapy Infusion of Skull Base Tumors.

Cornelis F, Lis E, Tabar V, Lin A J Neurol Surg B Skull Base. 2025; 86(1):34-38.

PMID: 39881746 PMC: 11774602. DOI: 10.1055/a-2257-5590.


Safety and Outcomes of an On-Demand Transfusion Strategy Versus Prophylactic Transfusion of Platelets in Patients With Liver Cirrhosis and Severe Thrombocytopenia Undergoing High-Risk Procedures: A Analysis of Two Randomized Controlled Trials.

Biswas S, Gupta S, Mehta S, Swaroop S, Aggarwal A, Agarwal A J Clin Exp Hepatol. 2025; 15(3):102467.

PMID: 39822652 PMC: 11733035. DOI: 10.1016/j.jceh.2024.102467.


Treating recurrent hemarthrosis after knee arthroplasty with selective embolization: a cohort study of 56 patients.

Sirola S, Heikkinen J, Kerimaa P, Kariniemi J, Niinimaki T Acta Orthop. 2025; 96():33-37.

PMID: 39786206 PMC: 11714783. DOI: 10.2340/17453674.2024.42660.